SavedAdd your journal

Journals / Turkish Neurosurgery / 2020 / Cilt: 30 - Sayı: 2

The Efficacy and Safety of Microvascular Decompression for Hemifacial Spasm: A Retrospective Analysis of Surgical Outcomes and Complications

Ahmet BEKAR
Turgut KUYTU
Alper TÜRKKAN
Oguz ALTUNYUVA
Pınar ESER OCAK
Pages
231–236
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No mortalitywas observed in this series.CONCLUSION: MVD is a safe and effective option for patients with HFS that is resistant to medical treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To determine the efficacy and safety of microvascular decompression (MVD) for hemifacial spasm (HFS) by retrospectivelyreviewing our results.MATERIAL and METHODS: A total of 55 patients who underwent MVD in our clinic between 2003 and 2017 were retrospectivelyanalyzed.
📊
Key Findings & Data:Clinical outcome results, recurrence rates, and surgical complications were noted.RESULTS: Thirty-six patients were female (65%).
💡
Conclusion & Impact:No mortalitywas observed in this series.CONCLUSION: MVD is a safe and effective option for patients with HFS that is resistant to medical treatment.
🔬Design:Review & Systematic Survey
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To determine the efficacy and safety of microvascular decompression (MVD) for hemifacial spasm (HFS) by retrospectivelyreviewing our results.MATERIAL and METHODS: A total of 55 patients who underwent MVD in our clinic between 2003 and 2017 were retrospectivelyanalyzed. Clinical outcome results, recurrence rates, and surgical complications were noted.RESULTS: Thirty-six patients were female (65%). The mean age of the patients was 51.3 years. The mean duration of the complaintwas 46.4 months. In 45 patients (82%), HFS was completely resolved within the first 6 months after the surgery. Five patients(9%) with recurrent symptoms were reoperated within the first year of the surgery. HFS symptoms of five patients (9%) completelyceased initially, but started again and reoperation was required due to failure of alternative treatments. Delayed facial nerve palsyand hearing loss were noted in one patient for each (2%). Cerebrospinal fluid leak was observed in two patients (4%). No mortalitywas observed in this series.CONCLUSION: MVD is a safe and effective option for patients with HFS that is resistant to medical treatment.

🔖

Cite This Article

BEKAR, A., KUYTU, T., TÜRKKAN, A., ALTUNYUVA, O., OCAK, P. E. (2020). The Efficacy and Safety of Microvascular Decompression for Hemifacial Spasm: A Retrospective Analysis of Surgical Outcomes and Complications. Turkish Neurosurgery, Cilt: 30 - Sayı: 2, 231–236. https://ajindex.com/articles/404329

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abbruzzese G, Berardelli A, Defazio G: Hemifacial spasm. Handb Clin Neurol 100:675-680, 2011 2. Barker FG, Jannette PJ, Bissonette DJ: Microvascular decompression for hemifacial spasm. J Neurosurg 82:201- 210, 1995 3. Dannenbaum M, Lega BC, Suki D, Harper RL, Yoshor D: Microvascular decompression for hemifacial spasm: Long-term results from 114 operations performed without neurophysiological monitoring. J Neurosurg 109:410-415, 2008 4. Erbas YC, Pusat S, Ata GK, Erdogan E: In-situ cranioplasty after microvascular decompression: A technical note. Turk Neurosurg 27(3):479-481, 2017 5. Fujimaki T, Son JH, Takanashi S, Ishii T, Furuya K, Mochizuki T, Ueno T, Nakagomi T: Preservation of the lesser occipital nerve during microvascular decompression for hemifacial spasm. Technical note. J Neurosurg 107:1235-1237, 2007 6. Guclu B, Sindou M, Meyronet D, Streichenberger N, Simon E, Mertens P: Cranial nerve vascular compression syndromes of the trigeminal, facial and vago-glossopharyngeal nerves: Comparative anatomical study of the central myelin portion and transitional zone; correlations with incidences of corresponding hyperactive dysfunctional syndromes. ActaNeurochir (Wien) 153:2365-2375, 2011 7. Han JS, Lee JA, Kong DS, Park K: Delayed cranial nerve palsy after microvascular decompression for hemifacial spasm. J Korean Neurosurg Soc 52: 288-292, 2012 8. Hanakita J, Kondo A: Serious complications of microvascular decompression operations for trigeminal neuralgia and hemifacial spasm. Neurosurgery 22:348-352, 1998 9. Horimoto C, Toba T, Yamaga S, Tsujimura M: Subfascial temporalis dissection preserving the facial nerve in pterional craniotomy-technical note. Neurol Med Chir (Tokyo) 32:36,37, 1992 10. Huh R, Han IB, Moon JY, Chang JW, Chung SS: Microvascular decompression for hemifacial spasm: Analyses of operative complications in 1582 consecutive patients. Surg Neurol 69:153-157, 2008 11. Jannetta PJ: Microsurgical exploration and decompression of the facial nerve in hemifacial spasm. Curr Top Surg Res 2:217- 220, 1970 12. Joo WI, Lee KJ, Park HK, Chough CK, Rha HK: Prognostic value of intra-operative lateral spread response monitoring during microvascular decompression in patients with hemifacial spasm. J Clin Neurosci 15:1335-1339, 2008 13. Kemp LW, Reich SG: Hemifacial spasm. Curr Treat Options Neurol 6:175-179, 2004 14. Kim BT, Hwang SC, Chang JC, Shin WH, Choi SK, Byun BJ: Delayed facial palsy following microvascular decompression in hemifacial spasm pat